ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
A4GALT |
Q9NPC4
|
alpha 1,4-galactosyltransferase (P blood group)
|
|
7.7E-06 |
0.751 |
0.346 |
ASPG |
Q86U10
|
asparaginase
|
|
6.2E-13 |
0.559 |
0.654 |
ARID1A |
O14497
|
AT-rich interaction domain 1A
|
|
1.00 |
0.455 |
0.846 |
BBC3 |
Q96PG8 Q9BXH1
|
BCL2 binding component 3
|
|
4.0E-03 |
0.517 |
0.769 |
BCL2L11 |
O43521
|
BCL2 like 11
|
|
0.89 |
0.510 |
0.731 |
BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
CES2 |
O00748
|
carboxylesterase 2
|
Enzyme
|
3.6E-16 |
0.584 |
0.731 |
CASP1 |
P29466
|
caspase 1
|
Enzyme
|
3.5E-05 |
0.413 |
0.885 |
CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
CD22 |
P20273
|
CD22 molecule
|
|
0.80 |
0.556 |
0.615 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
CCT6B |
Q92526
|
chaperonin containing TCP1 subunit 6B
|
Chaperone
|
5.7E-11 |
0.890 |
0.154 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
CRLF2 |
Q9HC73
|
cytokine receptor like factor 2
|
Signaling
|
3.3E-07 |
0.615 |
0.538 |
EBI3 |
Q14213
|
Epstein-Barr virus induced 3
|
Signaling
|
0.11 |
0.474 |
0.808 |
FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
FTCD |
O95954
|
formimidoyltransferase cyclodeaminase
|
Enzyme
|
5.5E-15 |
0.722 |
0.423 |
GNA13 |
Q14344
|
G protein subunit alpha 13
|
Enzyme modulator
|
0.87 |
0.656 |
0.538 |
HLF |
Q16534
|
HLF transcription factor, PAR bZIP family member
|
Nucleic acid binding
|
0.95 |
0.628 |
0.615 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
ID3 |
Q02535
|
inhibitor of DNA binding 3, HLH protein
|
Transcription factor
|
0.72 |
0.615 |
0.692 |